cd30 | CD30 - Wikipedia

Keyword	CPC	PCC	Volume	Score	Length of keyword
cd30	1.62	0.6	6592	93	4

Keyword	CPC	PCC	Volume	Score
cd30	1.73	1	4074	21
cd300ld	1.57	1	32	13
cd300lf	0.58	0.3	7544	48
cd303	0.59	0.9	5639	12
cd301	0.05	1	4135	9
cd300a	0.11	0.9	4580	48
cd302	0.14	0.8	9551	56
cd305837	1.7	1	3084	40
cd300e	0.96	0.4	9056	90
cd30l	0.68	0.7	4020	76
cd304	1.98	0.9	6716	84
cd309	1.56	0.6	3443	5
cd30 pathology outlines	1.71	1	4961	15
cd3000	1.79	0.2	5871	80
cd30 mp3	0.78	0.1	2519	48
cd30 marker	0.77	0.7	5688	79
cd30 adc	1.53	0.1	2458	87
cd300f	0.42	0.5	1141	92
cd30 antibody	1.21	0.5	4886	69
cd30 car-t	1.17	0.7	6009	56
cd30 positive lymphoma	0.76	0.4	2047	66
cd30 positive	0.89	0.7	8087	81
cd30 expression	0.34	0.7	662	78
cd30 boule du gard	1.9	1	9554	62
cd300e macrophage	0.19	0.1	7307	92

Search Results related to cd30 on Search Engine

CD30 - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/CD30

WEBCD30 is the target of the FDA approved therapeutic brentuximab vedotin (Adcetris). It is approved for use in: Hodgkin lymphoma (HL) (brentuximab vedotin) after failure of autologous stem cell transplant (ASCT) HL in patients who are not ASCT candidates after failure of at least 2 multiagent chemotherapy regimens.

DA: 74 PA: 30 MOZ Rank: 98

Understanding CD30 biology and therapeutic targeting: a ... - Nature
nature.com

https://www.nature.com/articles/bcj201785

WEBSep 8, 2017 · CD30 is a member of the tumor necrosis factor receptor superfamily. It is characteristically expressed in certain hematopoietic malignancies, including anaplastic large cell lymphoma and Hodgkin...

DA: 23 PA: 79 MOZ Rank: 13

Understanding CD30 biology and therapeutic targeting: a historical
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709754/

WEBSep 8, 2017 · CD30 ligand (CD30L, also known as TNFSF8 or CD153) is a membrane-bound cytokine with sequence homology to other members of the tumor necrosis factor (TNF) family. 4 CD30L can be detected in vitro on a subset of activated lymphocytes, histiocytes and granulocytes, and has been demonstrated on Reed–Sternberg cells and some T-cell …

DA: 28 PA: 22 MOZ Rank: 92

Pathology Outlines - CD30
pathologyoutlines.com

https://www.pathologyoutlines.com/topic/cdmarkerscd30.html

WEBCD30, also known as BerH2, Ki1 or TNFRSF8, is a transmembrane glycoprotein receptor that belongs to the tumor necrosis factor receptor (TNFR) and was first identified in Hodgkin lymphoma cell lines but also expressed in normal activated B and T cells.

DA: 35 PA: 59 MOZ Rank: 17

The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341339/

WEBJul 5, 2023 · CD30, also known as TNFRSF8 (tumor necrosis factor receptor superfamily member 8), is a protein receptor that is heavily glycosylated inside the Golgi apparatus, as well as a tumor marker that is found on the surface of specific cells in the body, including certain immune cells and cancer ones.

DA: 15 PA: 96 MOZ Rank: 72

CD30: from basic research to cancer therapy - PMC - National …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992519/

WEBThe picture emerging is that one of the primary functions of CD30 is the control of memory cells providing costimulation and trafficking information or inducing apoptosis in a microenvironment and cytokine milieu-dependent manner. Keywords: Memory, CCR7, Asthma, Colitis, Mucosal immunity, Th17, Hodgkin, ALCL. Go to:

DA: 71 PA: 76 MOZ Rank: 72

Understanding CD30 biology and therapeutic targeting: a ... - PubMed
nih.gov

https://pubmed.ncbi.nlm.nih.gov/28885612/

WEBPMID: 28885612. PMCID: PMC5709754. DOI: 10.1038/bcj.2017.85. Abstract. CD30 is a member of the tumor necrosis factor receptor superfamily. It is characteristically expressed in certain hematopoietic malignancies, including anaplastic large cell lymphoma and Hodgkin lymphoma, among others.

DA: 64 PA: 35 MOZ Rank: 8

The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment
mdpi.com

https://www.mdpi.com/2073-4409/12/13/1783

WEBJul 5, 2023 · CD30, also known as TNFRSF8 (tumor necrosis factor receptor superfamily member 8), is a protein receptor that is heavily glycosylated inside the Golgi apparatus, as well as a tumor marker that is found on the surface of specific cells in the body, including certain immune cells and cancer ones.

DA: 7 PA: 98 MOZ Rank: 80

CD30 - an overview | ScienceDirect Topics
sciencedirect.com

https://www.sciencedirect.com/topics/neuroscience/cd30

WEBCD30 is a TNFR-related surface protein expressed by activated (but not resting) Tand B cells, while its ligand CD30L (CD153) is a TNF-related transmembrane protein primarily expressed on activated T and B cells, eosinophils, and macrophages.

DA: 6 PA: 23 MOZ Rank: 65

Frontiers | Mechanism of action and therapeutic targeting of CD30
frontiersin.org

https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1301437/full

WEBDec 21, 2023 · CD30 is a member of the tumor necrosis factor receptor superfamily (TNFRSF), the expression of which is important for the diagnosis of a variety of lymphomas. For example, nearly 100% of tumor cells in patients with cHL and ALCL express CD30, making CD30 a diagnostic marker for these two types of lymphomas.

DA: 71 PA: 36 MOZ Rank: 33